Home Renal Dialysis Machine Offers Patients More Freedom
|
By HospiMedica International staff writers Posted on 18 May 2009 |
A new home dialysis machine helps patients with kidney failure and end stage renal disease (ESRD) self-administer peritoneal dialysis at home while they sleep.
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
The Liberty Cycler is intended for use in automated peritoneal dialysis (APD) therapy, regulating the exchange of used and fresh dialysis fluid while the patient sleeps; but unlike hemodialysis, the Liberty does not require needles. The Liberty Cycler fills and empties the abdomen with dialysate three to five times at night during sleep; in the morning, dialysate flows into the abdomen, and the catheter is detached from the system. The dialysate is carried in the peritoneal cavity during the day. During that time, normal daily activities can be maintained. At night, the catheter is reattached to the cycler before sleep, to perform APD one again.
The Liberty Cycler features a large color touch screen that gives easy to follow directions accompanied by pictures, an easy-to-load APD treatment cassette, and special connectors that are automatically inserted into the catheter lumen, making it easy to perform dialysate exchanges. The Liberty Cycler has a small footprint, small enough to fit on a nightstand, and requires no special plumbing or electrical hook-ups. The Liberty Cycler is available only through the dialysis facilities of the developer Fresenius Medical Care (Bad Homburg, Germany).
"Fresenius Medical Care recognizes that many dialysis patients have active lifestyles, and want more choices for treatment,” said Michael Lazarus, M.D., chief medical officer and senior executive VP of Fresenius Medical Care North America. "Many patients have discovered that dialyzing while they sleep provides them with the freedom to continue to pursue their careers, care for their families, or enjoy their years of retirement.”
The fluids used in APD contain either a glucose and amino acid solution or a compound called icodextrin to remove water from the patients blood, with the glucose solution most commonly used. The glucose "strength” (1.5%, 2.5% or 4.25%) of the solution determines how much water is removed--the higher the concentration, the greater the effect. The amino acids in the solution are used to improve the patient's nutritional condition. The benefits of the icodextrin fluid, on the other hand, are that it removes more water than the glucose solution for longer exchange intervals, and that it is glucose- free, which is advantageous both for the peritoneum and the body as a whole.
Related Links:
Fresenius Medical Care
Latest Critical Care News
- Inhaled Analgesic Matches Morphine for Prehospital Trauma Pain
- FDA Clears Tongue-Applied Neuromodulation System for Stroke Gait Rehabilitation
- Eye Test May Predict Return of Consciousness After Severe Brain Injury
- Medical Drone Program Improves Blood Access and Patient Survival
- AI System Enables Real-Time Sepsis Quality Assessment and Improves Adherence
- AI Detects Hidden ECG Marker of Sudden Cardiac Death
- FDA-Cleared AI Wearable Monitor Detects Opioid-Related Respiratory Risk in Hospitals
- Mitral Valve Repair Device Receives EU Approval for Functional Regurgitation
- AI Risk Score Reveals Hidden Hypertension-Related Organ Damage
- AI Tool Predicts Bronchopulmonary Dysplasia Risk in Preterm Infants
- Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants
- AI Tool Identifies Children With Pneumonia Requiring Hospital Care
- AI Ultrasound System Improves Safety of Blood–Brain Barrier Opening
- CE-Marked Smartphone AI Enables Autonomous Skin Cancer Assessment at Point of Care
- Handheld Optical Device Screens for Early Necrotizing Enterocolitis in Preterm Infants
- Home Blood Pressure Telemonitoring Linked to Fewer Cardiovascular Events
Channels
Artificial Intelligence
view channel
AI Trends Report Guides Responsible, Effective Healthcare Deployment
Hospitals are under growing pressure to adopt artificial intelligence tools that improve safety, efficiency, and continuity of care without compromising quality. At the same time, clinicians need clearer... Read more
Privacy-Preserving AI Protects Sensitive Information in ECG Data
Artificial intelligence applied to electrocardiography can extract more than cardiac rhythm. Algorithms can infer age, sex, race, and even identity from electrocardiogram (ECG) signals, creating privacy... Read moreSurgical Techniques
view channel
Aortic Arch Remodeling Device Improves Type I Dissection Repair
Acute DeBakey Type I aortic dissection is an emergent tear of the ascending aorta that can extend into the arch and descending thoracic aorta. Rapid ischemic complications and high early mortality make... Read more
Intravesical CAR T Therapy Shows Promise for Bladder Cancer Treatment
Bladder cancer is common and frequently recurs after initial therapy, exposing patients to repeated procedures and cumulative toxicity. High‑risk disease often progresses despite intravesical drugs or... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
Atrial fibrillation is an erratic, quivering heartbeat and a leading cause of stroke. Catheter ablation is widely used to interrupt arrhythmogenic tissue, yet many patients—especially with persistent ... Read moreAI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
Artificial intelligence (AI) is increasingly used to estimate risks for conditions such as sepsis, heart disease, and cancer, yet many models remain difficult for clinicians to interpret or trust.... Read morePoint of Care
view channel
AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
Keratinocyte skin cancers, including basal cell and squamous cell carcinoma, account for a substantial share of dermatology workload in the United States and require accurate triage to guide biopsy decisions.... Read more







